Integral Health Asset Management, LLC
Registered adviserFiling Date
Global Rank
#1,394
/ 8,818
▲ 28
Top Industry
Biotechnology
62.5%
Period ended 4 months ago
Filed Aug 14, 2026 · 2mo
26 quarters · since Mar 2020
Regulatory profile
From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.
Holder type
Registered adviser
Form ADV roster, Oct 1, 2026
Regulatory AUM
$1,872,690,688
Main clients
Pooled investment vehicles
(100% of AUM)
Private funds
1 fund
· Hedge funds
Focus by fund count, roster of Oct 1, 2026
$60,245,366 gross assets
LEI
5493009OFHWP89BLY397
Private funds on Schedule D 7.B.(1)
As filed Mar 27, 2024; SEC's bulk Form ADV archive ends with 2024 filings.
$51,738,089 gross assets in 1 fund
Hedge funds
$51,738,089
(1)
Form ADV history
Monthly rosters from Dec 2019; each row is a run with the same figures, newest first.
| Rosters | Regulatory AUM | Main clients |
|---|---|---|
| Apr 2026 to Oct 2026 | $1,872,690,688 | Pooled investment vehicles (100%) |
| Apr 2025 to Mar 2026 | $1,190,982,523 | Pooled investment vehicles (100%) |
| Apr 2024 to Mar 2025 | $815,150,147 | Pooled investment vehicles (100%) |
| May 2023 to Mar 2024 | $656,126,262 | Pooled investment vehicles (92%) |
| Apr 2023 | $656,126,262 | Pooled investment vehicles (92%) |
| Apr 2022 to Mar 2023 | $424,852,220 | Pooled investment vehicles (100%) |
3 earlier changes not shown.
Portfolio style
Measured from the filed 13F common-share book for Jun 30, 2026, never from the firm's own description.
Style
Diversified active
Top 10 weight 46.5%, 28.9 effective positions, active share 94.8% against the Russell 2000 as of 2026-06-30; it meets none of the index-like, systematic-like or concentrated tests
Turnover
Medium turnover
86.8% over the last four quarters (30% to under 100%)
Horizon
Horizon unknown
The value-weighted holding period is at least 7.5 quarters, but 5.6% of the book was already held when coverage starts
Closest benchmark: the Russell 2000 as of 2026-06-30, active share 94.8%; sector active share 90.9% against the combined 13F book's sector weights.
Over time 26 measured quarters
How the bands are measured
Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
90 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
13.3%
+0.5 pts
Top 5
33.1%
−5.8 pts
Top 10
47.0%
−4.8 pts
HHI
377
Diversified−93
Portfolio Trend
26 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $2,531,730,801 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
23 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| IVA | Inventiva S.A. | +1,120,000 | 1,520,000 | $5,745,600 | |
| CVS | CVS HEALTH Corp | +950,000 | 1,100,000 | $113,795,000 | |
| TNGX | Tango Therapeutics, Inc. | +550,000 | 1,000,000 | $31,260,000 | |
| — | +525,000 | 675,000 | $14,343,750 | ||
| ORIC | Oric Pharmaceuticals, Inc. | +500,000 | 1,900,000 | $20,577,000 | |
| EW | Edwards Lifesciences Corp | +455,000 | 625,000 | $56,537,500 | |
| EWTX | Edgewise Therapeutics, Inc. | +400,000 | 2,000,000 | $81,260,000 | |
| BSX | Boston Scientific Corp | +350,000 | 900,000 | $38,412,000 | |
| ERAS | Erasca, Inc. | +300,000 | 1,000,000 | $18,320,000 | |
| AXSM | Axsome Therapeutics, Inc. | +265,000 | 300,000 | $73,431,000 | |
| SRRK | Scholar Rock Holding Corp | +250,000 | 750,000 | $41,250,000 | |
| NVST | Envista Holdings Corp | +250,000 | 600,000 | $15,810,000 | |
| ACHC | Acadia Healthcare Company, Inc. | +200,000 | 400,000 | $11,812,000 | |
| VERA | Vera Therapeutics, Inc. | +150,000 | 1,750,000 | $75,092,500 | |
| DFTX | Definium Therapeutics, Inc. | +150,000 | 550,000 | $25,872,000 | |
| DGX | Quest Diagnostics Inc | +140,000 | 200,000 | $42,390,000 | |
| INSM | INSMED Inc | +100,000 | 1,600,000 | $170,592,000 | |
| LNTH | Lantheus Holdings, Inc. | +65,000 | 190,000 | $21,078,600 | |
| RLMD | Relmada Therapeutics, Inc. | +50,000 | 500,000 | $3,460,000 | |
| BIIB | Biogen Inc. | +40,000 | 100,000 | $21,606,000 | |
| CAH | Cardinal Health Inc | +30,000 | 300,000 | $71,268,000 | |
| LIVN | LivaNova PLC | +30,000 | 180,000 | $14,801,400 | |
| SION | Sionna Therapeutics, Inc. | +25,000 | 75,000 | $3,299,250 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
21 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| RZLT | Rezolute, Inc. | −1,500,000 | 500,000 | $2,600,000 | |
| LFST | LifeStance Health Group, Inc. | −1,300,000 | 3,000,000 | $32,130,000 | |
| SANA | Sana Biotechnology, Inc. | −1,200,000 | 2,000,000 | $6,980,000 | |
| BTSG | BrightSpring Health Services, Inc. | −700,000 | 550,000 | $38,357,000 | |
| RGNX | REGENXBIO Inc. | −700,000 | 800,000 | $9,584,000 | |
| ALHC | Alignment Healthcare, Inc. | −575,000 | 2,000,000 | $47,620,000 | |
| CNC | Centene Corp | −350,000 | 300,000 | $19,257,000 | |
| BHVN | Biohaven Ltd. | −300,000 | 700,000 | $10,416,000 | |
| MLYS | Mineralys Therapeutics, Inc. | −300,000 | 450,000 | $12,141,000 | |
| TARA | Protara Therapeutics, Inc. | −250,000 | 1,500,000 | $5,730,000 | |
| COGT | Cogent Biosciences, Inc. | −150,000 | 200,000 | $7,740,000 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | −100,000 | 200,000 | $16,302,000 | |
| ALMS | Alumis Inc. | −100,000 | 700,000 | $19,698,000 | |
| MRK | Merck & Co., Inc. | −75,000 | 350,000 | $44,975,000 | |
| ASND | Ascendis Pharma A/S | −70,000 | 45,000 | $12,002,400 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | −50,000 | 550,000 | $61,066,500 | |
| OLMA | Olema Pharmaceuticals, Inc. | −50,000 | 100,000 | $1,251,000 | |
| NVS | Novartis AG | −50,000 | 200,000 | $31,344,000 | |
| REGN | Regeneron Pharmaceuticals, Inc. | −45,000 | 40,000 | $24,941,600 | |
| ELV | Elevance Health, Inc. | −25,000 | 50,000 | $19,336,500 | |
| GKOS | GLAUKOS Corp | −25,000 | 150,000 | $20,964,000 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ABT | Abbott Laboratories | 400,000 | $36,296,000 | |
| UNH | Unitedhealth Group Inc | 85,000 | $35,328,550 | |
| THC | Tenet Healthcare Corp | 165,000 | $30,868,200 | |
| SYRE | Spyre Therapeutics, Inc. | 325,000 | $28,853,500 | |
| NVO | Novo Nordisk A S | 600,000 | $28,764,000 | |
| TVTX | Travere Therapeutics, Inc. | 375,000 | $21,303,750 | |
| MDT | Medtronic plc | 200,000 | $15,646,000 | |
| WAT | Waters Corp | 40,000 | $15,001,600 | |
| IRTC | iRhythm Holdings, Inc. | 90,000 | $10,705,500 | |
| IART | Integra Lifesciences Holdings Corp | 550,000 | $9,878,000 | |
| GEHC | GE HealthCare Technologies Inc. | 150,000 | $9,601,500 | |
| ABSI | Absci Corp | 800,000 | $9,272,000 | |
| BRKR | Bruker Corp | 150,000 | $9,027,000 | |
| COR | Cencora, Inc. | 30,000 | $8,489,400 | |
| ELVN | Enliven Therapeutics, Inc. | 150,000 | $7,612,500 | |
| BIOA | BioAge Labs, Inc. | 300,000 | $7,353,000 | |
| JAZZ | Jazz Pharmaceuticals plc | 30,000 | $7,229,100 | |
| ALKS | Alkermes plc. | 100,000 | $5,240,000 | |
| KARD | Kardigan, Inc. | 200,000 | $4,770,000 | |
| BNTX | BioNTech SE | 50,000 | $4,652,500 | |
| INSP | Inspire Medical Systems, Inc. | 100,000 | $4,461,000 | |
| TRVI | Trevi Therapeutics, Inc. | 200,000 | $3,730,000 | |
| IDYA | IDEAYA Biosciences, Inc. | 100,000 | $3,727,000 | |
| CLDX | Celldex Therapeutics, Inc. | 100,000 | $3,721,000 | |
| MOBI | Mobia Medical, Inc. | 250,000 | $3,350,000 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| AZN | Astrazeneca PLC | 250,000 | $49,305,000 | |
| FMS | Fresenius Medical Care AG | 775,000 | $17,484,000 | |
| ISRG | Intuitive Surgical Inc | 35,000 | $16,134,650 | |
| TARS | Tarsus Pharmaceuticals, Inc. | 200,000 | $14,030,000 | |
| GILD | Gilead Sciences, Inc. | 100,000 | $13,937,000 | |
| ELAN | Elanco Animal Health Inc | 550,000 | $13,161,500 | |
| DNTH | Dianthus Therapeutics, Inc. | 150,000 | $12,588,000 | |
| DXCM | Dexcom Inc | 175,000 | $10,990,000 | |
| — | 325,000 | $10,881,000 | ||
| IRON | Disc Medicine, Inc. | 170,000 | $10,869,800 | |
| NRIX | Nurix Therapeutics, Inc. | 700,000 | $10,850,000 | |
| COO | Cooper Companies, Inc. | 150,000 | $10,725,000 | |
| TMO | Thermo Fisher Scientific Inc. | 20,000 | $9,830,600 | |
| IONS | Ionis Pharmaceuticals Inc | 125,000 | $9,386,250 | |
| CELC | Celcuity Inc. | 80,000 | $9,131,200 | |
| SNDX | Syndax Pharmaceuticals Inc | 350,000 | $8,176,000 | |
| VKTX | Viking Therapeutics, Inc. | 250,000 | $8,135,000 | |
| CAPR | Capricor Therapeutics, Inc. | 200,000 | $6,080,000 | |
| IQV | Iqvia Holdings Inc. | 35,000 | $5,968,900 | |
| PTGX | Protagonist Therapeutics, Inc | 50,000 | $5,270,000 | |
| EVMN | Evommune, Inc. | 225,000 | $5,172,750 | |
| ZBH | Zimmer Biomet Holdings, Inc. | 50,000 | $4,521,000 | |
| IMCR | Immunocore Holdings plc | 100,000 | $3,015,000 | |
| MAZE | Maze Therapeutics, Inc. | 100,000 | $2,985,000 | |
| UNCY | Unicycive Therapeutics, Inc. | 225,000 | $1,480,500 | |
| No positions match the current search. | ||||
90 tracked positions ·
$2,531,730,801 total
· filing declares
92 positions · $2,531,730,300
· as of Jun 30, 2026
Showing 1–50
of 90 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| RVMD |
Revolution Medicines, Inc.
PUT
+ SHARES
Healthcare
|
Reduced | 1,800,000 | $337,104,000 | 13.32% | |
| INSM |
INSMED Inc
Healthcare
|
Added | 1,600,000 | $170,592,000 | 6.74% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Reduced | 1,600,000 | $136,304,000 | 5.38% | |
| CVS |
CVS HEALTH Corp
Healthcare
|
Added | 1,100,000 | $113,795,000 | 4.49% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Added | 2,000,000 | $81,260,000 | 3.21% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Added | 1,750,000 | $75,092,500 | 2.97% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Added | 300,000 | $73,431,000 | 2.90% | |
| CAH |
Cardinal Health Inc
Healthcare
|
Added | 300,000 | $71,268,000 | 2.81% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Held | 2,000,000 | $70,780,000 | 2.80% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Reduced | 550,000 | $61,066,500 | 2.41% | |
| EW |
Edwards Lifesciences Corp
Healthcare
|
Added | 625,000 | $56,537,500 | 2.23% | |
| ALHC |
Alignment Healthcare, Inc.
Healthcare
|
Reduced | 2,000,000 | $47,620,000 | 1.88% | |
| MRK |
Merck & Co., Inc.
Healthcare
|
Reduced | 350,000 | $44,975,000 | 1.78% | |
| NVO |
Novo Nordisk A S
CALL
+ SHARES
Healthcare
|
NEW | 900,000 | $43,146,000 | 1.70% | |
| DGX |
Quest Diagnostics Inc
Healthcare
|
Added | 200,000 | $42,390,000 | 1.67% | |
| QURE |
uniQure N.V.
Healthcare
|
Held | 900,000 | $41,454,000 | 1.64% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Added | 750,000 | $41,250,000 | 1.63% | |
| BSX |
Boston Scientific Corp
Healthcare
|
Added | 900,000 | $38,412,000 | 1.52% | |
| BTSG |
BrightSpring Health Services, Inc.
Healthcare
|
Reduced | 550,000 | $38,357,000 | 1.52% | |
| ABT |
Abbott Laboratories
Healthcare
|
NEW | 400,000 | $36,296,000 | 1.43% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
NEW | 85,000 | $35,328,550 | 1.40% | |
| LFST |
LifeStance Health Group, Inc.
Healthcare
|
Reduced | 3,000,000 | $32,130,000 | 1.27% | |
| NVS |
Novartis AG
Healthcare
|
Reduced | 200,000 | $31,344,000 | 1.24% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Added | 1,000,000 | $31,260,000 | 1.23% | |
| THC |
Tenet Healthcare Corp
Healthcare
|
NEW | 165,000 | $30,868,200 | 1.22% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
NEW | 325,000 | $28,853,500 | 1.14% | |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
Added | 550,000 | $25,872,000 | 1.02% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Held | 150,000 | $25,281,000 | 1.00% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
Reduced | 40,000 | $24,941,600 | 0.99% | |
| IONS |
Ionis Pharmaceuticals Inc
CALL
Healthcare
|
Added | 300,000 | $23,787,000 | 0.94% | |
| BIIB |
Biogen Inc.
Healthcare
|
Added | 100,000 | $21,606,000 | 0.85% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
NEW | 375,000 | $21,303,750 | 0.84% | |
| LNTH |
Lantheus Holdings, Inc.
Healthcare
|
Added | 190,000 | $21,078,600 | 0.83% | |
| GKOS |
GLAUKOS Corp
Healthcare
|
Reduced | 150,000 | $20,964,000 | 0.83% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Added | 1,900,000 | $20,577,000 | 0.81% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Held | 275,000 | $20,482,000 | 0.81% | |
| VRTX |
Vertex Pharmaceuticals Inc
Healthcare
|
Held | 40,000 | $19,869,200 | 0.78% | |
| ALMS |
Alumis Inc.
Healthcare
|
Reduced | 700,000 | $19,698,000 | 0.78% | |
| ELV |
Elevance Health, Inc.
Healthcare
|
Reduced | 50,000 | $19,336,500 | 0.76% | |
| CNC |
Centene Corp
Healthcare
|
Reduced | 300,000 | $19,257,000 | 0.76% | |
| ERAS |
Erasca, Inc.
Healthcare
|
Added | 1,000,000 | $18,320,000 | 0.72% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Held | 15,000 | $17,991,451 | 0.71% | |
| ARWR |
Arrowhead Pharmaceuticals, Inc.
Healthcare
|
Reduced | 200,000 | $16,302,000 | 0.64% | |
| NVST |
Envista Holdings Corp
Healthcare
|
Added | 600,000 | $15,810,000 | 0.62% | |
| MDT |
Medtronic plc
Healthcare
|
NEW | 200,000 | $15,646,000 | 0.62% | |
| WAT |
Waters Corp
Healthcare
|
NEW | 40,000 | $15,001,600 | 0.59% | |
| LIVN |
LivaNova PLC
Healthcare
|
Added | 180,000 | $14,801,400 | 0.58% | |
|
|
Added | 675,000 | $14,343,750 | 0.57% | ||
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
Held | 25,000 | $13,423,750 | 0.53% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Held | 40,000 | $13,391,600 | 0.53% |
Showing the top 50 of 90 positions. Create a free account to see every position, past quarters, search, filters and CSV export.
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.